Wednesday, June 30, 2010

GlaxoSmithKline and MedTrust Online launch an oncology clinical trials iPhone app

GlaxoSmithKline (GSK) and MedTrust Online (an online physician portal) have launched a geolocating iPhone app that lets docs look up cancer clinical trials for their patients. Here are a few snippets from a June 4 press release:
With CancerTrials App, cancer doctors can easily find and share information about experimental therapies in clinical trials with their patients.  CancerTrials App provides a quick search menu based on 12 common cancers and more advanced features that refine searches based on criteria such as gender, age, trial status and more.  Once relevant trials are found, results can be mapped relative to the location of the iPhone or iPad running the application.
"GSK Oncology has always been interested in providing doctors and their patients with the access to the right information about the best therapies that improve patient outcomes," stated Jeffrey Bloss, M.D., Vice President, Medicine Development Leader for GSK Oncology.  "We are pleased to work with MedTrust Online to bring simple yet highly effective information-based solutions to the cancer community."
CancerTrials App is the first release of a mobile application for several platforms that connects to MedTrust Online's proprietary databases of oncology information at  Solutions for RIM's BlackBerry and Google's Android operating systems will be released over the next several months.  Oncologists using mobile communication devices will be able to share more with their patients as they search for the best therapies available in their communities.
About MedTrust Online, LLC
MedTrust Online LLC,, provides oncologists with clinically useful technology applications and solutions. MedTrust Online brings together experts in oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to capture, organize, analyze, integrate and present the most up-to-date medical facts from a vast array of sources. This data is provided to doctors in a comprehensive yet concise way at

No comments:

Post a Comment